Circulating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is associated with inefficient macro- and micronutrient metabolism, and alteration of circulating phospholipid compositions defines the signature of NAFLD. This current study aimed to assess the pattern of serum phospholipids in the spectrum of NAFLD, and its related comorbidities and genetic modifications. Methods: 97 patients with diagnosed NAFLD were recruited at a single center during 2013–2016. Based on histological and transient elastography assessment, 69 patients were divided into non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver (NAFL) subgroups. 28 patients served as healthy controls. Serum phospholipids were determined by liquid-chromatography mass spectrometry (LC-MS/MS). Results: The total content of phosphatidylcholine (PC) and sphingomyelin in the serum was significantly increased in NAFL and NASH patients, compared to healthy controls. In addition, serum lysophospatidylethanolamine levels were significantly decreased in NAFL and NASH individuals. Circulating PC species, containing linoleic and α-linolenic acids, were markedly increased in NAFLD patients with hypertension, compared to NAFLD patients without hypertension. The pattern of phospholipids did not differ between NAFLD patients with diabetes and those without diabetes. However, NAFLD patients with hyperglycemia (blood glucose level (BGL) >100 mg/dL) exhibited significantly a higher amount of monounsaturated phosphatidylethanolamine than those with low blood glucose levels. In addition, NAFLD patients with proven GG-genotype of PNPLA3, who were at higher risk for the development of progressive disease with fibrosis, showed lower levels of circulating plasmalogens, especially 16:0, compared to those with CC- and CG-allele. Conclusions: Our extended lipidomic study presents a unique metabolic profile of circulating phospholipids associated with the presence of metabolic risk factors or the genetic background of NAFLD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, conflicting results were reported for sphingomyelins, which were found to be both increased94,108,111,113 and decreased94,113,114 in MASLD.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · cited 1×
“A classical Folch method, which uses chloroform/methanol (3:2, v/v), was applied to the glass tubes [16].”
MethodGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · cited 4×
“showed a significant decrease of hepatic phosphatidiylcholine (PC) levels and hepatic lipid subclasses containing arachidonic acid (AA) in NAFLD patients [7].”
BackgroundResultInfluentialEpidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026 · cited 2×
“Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the western world, and is linked to increasing prevalence of obesity and diabetes [1,2].”
BackgroundBedossa, P., Poitou, C., Veyrie, N., Bouillot, J.-L., Basdevant, A., Paradis, V., Tordjman, J., & Clement, K. (2012) · Hepatology · doi:10.1002/hep.25889 · Cited by 903
Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis
Lieber, C. S. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.07.008 · Cited by 699
The plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655 · cited 2×
“reported low circulating serum plasmalogen levels in patients presenting with NASH in their lipidomics study [10].”
BackgroundHealth effects of dietary phospholipids
Küllenberg, D., Taylor, L. A., Schneider, M., & Massing, U. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-3 · Cited by 561
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
Cited by
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H., & Moshage, H. (2021) · Hepatology International · doi:10.1007/s12072-020-10121-2 · Cited by 432
Non-alcoholic fatty liver disease in lean individuals
Albhaisi, S., Chowdhury, A., & Sanyal, A. J. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.08.002 · Cited by 174
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“94 Also, con fl icting results were reported for sphingomyelins, which were found to be both increased 94,108,111,113 and decreased 94,113,114 in MASLD.”
Lipidomics in non-alcoholic fatty liver disease
Kartsoli, S., Kostara, C. E., Tsimihodimos, V., Bairaktari, E. T., & Christodoulou, D. K. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i8.436 · Cited by 163
Yamamoto, Y., Sakurai, T., Chen, Z., Inoue, N., Chiba, H., & Hui, S. (2022) · Nutrients · doi:10.3390/nu14030579 · Cited by 104
Pfohl, M., Ingram, L. M., Marques, E., Auclair, A., Barlock, B. J., Jamwal, R., Anderson, D. C., Cummings, B. S., & Slitt, A. L. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa148 · Cited by 70
Deng, Y., Chen, H., Huang, Y., Wang, Q., Chen, W., & Chen, D. (2022) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.2c00262 · Cited by 67
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Mocciaro, G., Allison, M., Jenkins, B., Azzu, V., Huang-Doran, I., Herrera-Marcos, L. V., Hall, Z., Murgia, A., Susan, D., Frontini, M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101728 · Cited by 56
Kupčová, V., Fedelešová, M., Bulas, J., Kozmonová, P., & Turecký, L. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193570 · Cited by 54
Montandon, S. A., Somm, E., Loizides‐Mangold, U., Vito, C. D., Dibner, C., & Jornayvaz, F. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-53346-4 · Cited by 59
Old age as a risk factor for liver diseases: Modern therapeutic approaches
Georgieva, M., Xenodochidis, C., & Krasteva, N. A. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112334 · Cited by 71
Ahmed, E., El-Derany, M. O., Anwar, A. M., Saied, E. M., & Magdeldin, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010210 · Cited by 50
BUNGAU, S. G., Behl, T., Ţiţ, D. M., Bănică, F., Bratu, O. G., Diaconu, C. C., Nistor-Cseppento, C. D., Bustea, C., Aron, R. A. C., & Vesa, C. M. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9327 · Cited by 49
Yamamoto, Y., Sakurai, T., Chen, Z., Furukawa, T., Gowda, S. G. B., Wu, Y., Nouso, K., Fujii, Y., Yoshikawa, Y., Chiba, H., et al. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02996-9 · Cited by 45
Schneider, C. V., Schneider, K. M., Conlon, D. M., Park, J., Vujkovic, M., Zandvakili, I., Ko, Y.-A., Trautwein, C., Carr, R. M., Strnad, P., et al. (2021) · Med · doi:10.1016/j.medj.2021.04.011 · Cited by 44
Bioactive signalling lipids as drivers of chronic liver diseases
Kaffe, E., Tisi, A., Magkrioti, C., Aidinis, V., Mehal, W. Z., Flavell, R. A., & Maccarrone, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.029 · Cited by 47
Liu, J., Wang, J., Zhou, Y., Han, H., Liu, W., Li, D., Li, F., Cao, D., & Lei, Q. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102165 · Cited by 46
Shama, S., Jang, H., Wang, X., Zhang, Y., Shahin, N. N., Motawi, T. K., Kim, S., Gawrieh, S., & Liu, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021034 · Cited by 44
Ren, F., Chen, Q., Chen, M., Chen, H., Zhou, Y., Zhang, H., & Chen, W. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104496 · Cited by 40
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
Mann, J. P., Pietzner, M., Wittemans, L. B., Rolfe, E. D. L., Kerrison, N. D., Imamura, F., Forouhi, N. G., Fauman, E., Allison, M. E., Griffin, J. L., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa162 · Cited by 38
Draijer, L. G., Froon-Torenstra, D., van Weeghel, M., Vaz, F. M., Bohte, A. E., Holleboom, A. G., Benninga, M. A., & Koot, B. G. P. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002875 · Cited by 43
Huang, W.-C., Xu, J.-W., Li, S., Ng, X. E., & Tung, Y. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00644-w · Cited by 43
Castañé, H., Baiges‐Gayà, G., Hernández‐Aguilera, A., Rodríguez‐Tomàs, E., Fernández‐Arroyo, S., Herrero, P., Delpino-Rius, A., Canela-Canela, N., Menéndez, J. A., Camps, J., et al. (2021) · Biomolecules · doi:10.3390/biom11030473 · Cited by 36
Tung, Y., Zeng, J., Ho, S., Xu, J.-W., Li, S., & Wu, J. (2021) · Antioxidants · doi:10.3390/antiox10111694 · Cited by 37
Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease
Zeng, Y., He, H., & An, Z. (2022) · Disease Markers · doi:10.1155/2022/1254014 · Cited by 28
Mazzini, F. N., Cook, F., Gounarides, J., Marciano, S., Haddad, L., Tamaroff, A. J., Casciato, P. C., Narvaez, A., Mascardi, M. F., Anders, M., et al. (2021) · Metabolomics · doi:10.1007/s11306-021-01810-6 · Cited by 27
Wu, Y., Chen, Z., Fuda, H., Tsukui, T., Wu, X., Shen, N., Saito, N., Chiba, H., & Hui, S. (2021) · Antioxidants · doi:10.3390/antiox10101602 · Cited by 28
Huang, L., Zhang, Z., Li, Y., Yi, P., Gu, W., Yang, J., Li, Y., Hao, X., & Yuan, C. (2022) · Organic Letters · doi:10.1021/acs.orglett.2c02240 · Cited by 24
Liu, L., Zhao, J., Zhang, R., Wang, X., Wang, Y., Chen, Y., & Feng, R. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114058 · Cited by 27
Defining NASH from a Multi-Omics Systems Biology Perspective
Niu, L., Sulek, K., Vasilopoulou, C. G., Santos, A., Albrechtsen, N. J. W., Rasmussen, S., Meier, F., & Mann, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204673 · Cited by 24
Anari, M., & Montgomery, M. K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115621 · Cited by 24
Park, S., Lee, J. J., Lee, S. M., Lee, J., Seo, C., Hwang, G., & Jung, J. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112999 · Cited by 23
Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach
Mouskeftara, T., Kalopitas, G., Liapikos, T., Arvanitakis, K., Germanidis, G. S., & Gika, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115965 · Cited by 20
Wu, Z. E., Fraser, K., Kruger, M. C., Sequeira, I. R., Yip, W. C. Y., Lu, L. W., Plank, L. D., Murphy, R., Cooper, G. J. S., Martin, J., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00854-x · Cited by 23
Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
Sessa, A. D., Riccio, S., Pirozzi, E., Verde, M., Passaro, A. P., Umano, G. R., Guarino, S., del Giudice, E. M., & Marzuillo, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i25.3815 · Cited by 20
Vural, H., Armutçu, F., Akyol, Ö., & Weiskirchen, R. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.10.018 · Cited by 23
Effects of differential regional PM2.5 induced hepatic steatosis and underlying mechanism
Yan, Z., Li, S., Chen, R., Xie, H., Wu, M., Nan, N., Xing, Q., Yun, Y., Qin, G., & Sang, N. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121220 · Cited by 20
Peng, H., Li, J., Xu, H., Wang, X., He, L., McCauley, N., Zhang, K. K., & Xie, L. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109187 · Cited by 18
He, D., Su, Y., Meng, D., Wang, X., Wang, J., & Ye, H. (2021) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2021.10.001 · Cited by 18
Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
Schattenberg, J. M., & Bergheim, I. (2019) · Nutrients · doi:10.3390/nu11030588 · Cited by 17
Shao, C., Xu, L., Lei, P., Wang, W., Feng, S., Ye, J., & Zhong, B. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-022-03760-6 · Cited by 19
Shin, G., Lee, H. M., Kim, N., Hur, J., Yoo, S., Park, Y. S., Park, H. S., Ryu, D., Park, M., Park, J. H., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16438 · Cited by 17
Gaskell, H., Ge, X., Désert, R., Das, S., Han, H., Lantvit, D. D., Guzman, G., & Nieto, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1448 · Cited by 16
Lüchtenborg, C., Niederhaus, B., Brügger, B., Popovic, B., & Fricker, G. (2020) · Lipids · doi:10.1002/lipd.12236 · Cited by 16
Du, S., Chen, X., Ren, R., Li, L., Zhang, B., Wang, Q., Meng, Y., Qiu, Z., Wang, G., Zheng, G., et al. (2024) · Food & Function · doi:10.1039/d4fo00586d · Cited by 15
Babu, A. F., Palomurto, S., Kärjä, V. J., Käkelä, P., Lehtonen, M., Hanhineva, K., Pihlajamäki, J., & Männistö, V. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.015 · Cited by 16
Shao, M., Lu, Y., Xiang, H., Wang, J., Ji, G., & Wu, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.971561 · Cited by 15
Bertran, L., Capellades, J., Abelló, S., Durán, J. M., Aguilar, C., Martínez, S., Sabench, F., Correig, X., Yanes, Ó., Auguet, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129789 · Cited by 15
Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
Gowda, D., Shekhar, C., Gowda, S. G. B., Chen, Y., & Hui, S. (2023) · Livers · doi:10.3390/livers3040045 · Cited by 15
Iannone, V., Lok, J., Babu, A. F., Gómez-Gallego, C., Willman, R.-M., Koistinen, V., Klåvus, A., Kettunen, M. I., Kårlund, A., Schwab, U., et al. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109307 · Cited by 16
Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population
Chae, W., Lee, K. J., Huh, K. Y., Moon, J. S., Ko, J. S., & Cho, J. (2022) · Metabolites · doi:10.3390/metabo12090881 · Cited by 15
Gautam, J., Kumari, D., Aggarwal, H., Gupta, S. K., Kasarla, S. S., Sarkar, S., Priya, M. R. K., Kamboj, P., Kumar, Y., & Dikshit, M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159348 · Cited by 11
Huneault, H. E., Gent, A., Cohen, C. C., He, Z., Jarrell, Z. R., Kamaleswaran, R., & Vos, M. B. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000375 · Cited by 13
Heintz, M. M., Kumar, R., Maner-Smith, K. M., Ortlund, E. A., & Baldwin, W. S. (2022) · Journal of Lipids · doi:10.1155/2022/7122738 · Cited by 12
Huneault, H. E., Chen, C., Cohen, C. C., Liu, X., Jarrell, Z. R., He, Z., DeSantos, K., Welsh, J. A., Maner-Smith, K. M., Ortlund, E. A., et al. (2024) · Metabolites · doi:10.3390/metabo14040191 · Cited by 11
SLMO transfers phosphatidylserine between the outer and inner mitochondrial membrane in Drosophila
Zhao, S., Jiang, X., Li, N., & Wang, T. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002941 · Cited by 13
Wang, J., Zheng, J., Ren, X., Wang, S., Wang, G., Hu, B., Yang, H., & Liu, H. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13120 · Cited by 12
Heymann, C. J. F., Mak, A. L., Holleboom, A. G., Verheij, J., Shiri‐Sverdlov, R., van Mil, S. W. C., Tushuizen, M. E., Koek, G. H., & Grefhorst, A. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02380-x · Cited by 11
Circulating glycerate predicts resilience to fructose-induced hepatic steatosis
Ramirez, C. B., Ahn, I. S., Rubtsova, V. I., Cely, I., Le, J., Kim, J., Jung, S., Kelly, M. E., Kim, Y., Bae, H., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.03.017 · Cited by 12
Cheng, Z., & Montgomery, M. K. (2025) · Clinical Science · doi:10.1042/cs20257631 · Cited by 10
The Changes in Plasmalogens: Chemical Diversity and Nutritional Implications—A Narrative Review
Chen, Z., Dong, C., Chen, L., Song, M., Zhou, X., Lv, D., & Li, Q. (2025) · Nutrients · doi:10.3390/nu17223497 · Cited by 11
Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD
Migni, A., Bartolini, D., Ceccarini, M. R., Galli, C., Cavaliere, G., Garetto, S., Lucci, J., & Galli, F. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2026.101380 · Cited by 10
Sourianarayanane, A., Brydges, C. R., & McCullough, A. J. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102402 · Cited by 9
Inoue, N., Sakurai, T., Yamamoto, Y., Chiba, H., & Hui, S. (2022) · BioFactors · doi:10.1002/biof.1868 · Cited by 7
Hou, Y., Deng, F., Guo, J., Lv, L., OuYang, H., Wang, X., Luo, Y., Chen, X., & Wang, F. (2023) · Endocrinology · doi:10.1210/endocr/bqad084 · Cited by 7
Qi, Z., Le, S., Cheng, R., Du, X., Zhao, C., Zhang, Z., Zhang, X., Feng, L., Schumann, M., Mao, L., et al. (2024) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003388 · Cited by 8
Metabolomics Signatures of Atherosclerosis in Cardiovascular Disease: A Narrative Systematic Review
Pibiri, M., Noto, A., Dalu, A., Muntoni, S., Kopeć, K. K., Spada, M., Atzori, L., & Piras, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228028 · Cited by 6
Jiang, Y., Zhao, L., Liu, Y., Fu, B., Zhi, F., Zhao, B., Liu, Y., Luo, S., Wang, J., Liu, X., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202500847r · Cited by 5
Bielawiec, P., Dziemitko, S., Konstantynowicz-Nowicka, K., Sztolsztener, K., Chabowski, A., & Harasim‐Symbor, E. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1401558 · Cited by 6
Obesity-diabetes-endocrinopathy – the metabolic connection
Kozakowski, J., Dudek, P., & Zgliczyński, W. (2022) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2022.4.12 · Cited by 4
Elingaard-Larsen, L. O., Villumsen, S. O., Justesen, L., Thuesen, A. C. B., Kim, M. G., Ali, M., Danielsen, E. R., Legido‐Quigley, C., van Hall, G., Hansen, T. F., et al. (2023) · Nutrients · doi:10.3390/nu15071590 · Cited by 4
Shin, G., Lee, H. M., Kim, N. Y., Yoo, S., Park, Y. S., Park, H. S., Ryu, D., Kim, K. P., & Kim, K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.01.462722 · Cited by 3
Semertzidis, A., Mouskeftara, T., Gika, H., Pousinis, P., Makedou, K., Goulas, A., Kountouras, J., & Pοlyzos, S. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133798 · Cited by 3
Makri, E. S., Mouskeftara, T., Gika, H., Xanthopoulos, K., Makri, E., Mavrommatis-Parasidis, P., Tsingotjidou, A., Cheva, A., Goulas, A., & Pοlyzos, S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199273 · Cited by 3
Virseda‐Berdices, A., Requena, B., Berenguer, J., Gónzalez-García, J., González-Riaño, C., Díez, C., Hontañón, V., Muñoz-García, P., Fernández‐Rodríguez, A., Barbas, C., et al. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102981 · Cited by 3
Weigand, K., Peschel, G., Höring, M., Krautbauer, S., Liebisch, G., Müller, M., & Buechler, C. (2025) · Biomedicines · doi:10.3390/biomedicines13112720 · Cited by 2
Lu, C.-H., Hsieh, Y.-R., Huang, S.-Y., Wang, W., Chang, C.-W., Panunggal, B., Chang, I., Chen, C.-L., Chang, C.-C., & Kao, W. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08450-y · Cited by 2
Inoue, N., Gowda, S. G. B., Gowda, D., Sakurai, T., Araki, A., Bamai, Y. A., Ketema, R. M., Kishi, R., Chiba, H., & Hui, S. (2024) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632241280352 · Cited by 2
Dong, L., Lin, S., Slavin, J., Gunnam, S., Cheng, Z., Nie, S., Leeming, M. G., Williamson, N. A., & Montgomery, M. K. (2025) · Diabetes · doi:10.2337/db25-0588 · Cited by 3
Tews, H. C., Huss, M., Elger, T., Liebisch, G., Höring, M., Loibl, J., Kandulski, A., Müller, M., & Buechler, C. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02889-3 · Cited by 1
Wu, M., Chen, S., Guo, W., Gu, S., Li, K., Shi, Y., Qian, Y., Sun, Y., Liu, Y., & Zhu, H. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128417 · Cited by 1
Martins, A. M. A., Garcia, J. H. P., & Eberlin, M. N. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1651643 · Cited by 1
AN ‘OMICS APPROACH TO DIET & STRUCTURE IMPACT ON PERFLUOROALKYL SUBSTANCE INDUCED LIVER DISEASE
Pfohl, M. (2019) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-pfohl-marisa-2019
NON-ALCOHOLIC FATTY LIVER DISEASE AND HYPERTENSION: CLINICAL VARIABILITY OF COMORBIDITY
Rozhdestvenska, A. O., Babak, O., & Zhelezniakova, N. (2020) · Inter Collegas · doi:10.35339/ic.7.3.131-138
Zhao, S., Jiang, X., Li, N., & Wang, T. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4502779
Phospholipid composition of bile and blood in rats under correction of experimental fatty hepatosis
Veselskyi, S., Pototskyi, A., Tomchuk, V., Gryshchenko, V., & Reshetnik, Y. (2023) · Ukrainian journal of veterinary sciences · doi:10.31548/veterinary3.2023.25
Editorial: New Perspectives on Hepatic Steatosis
Schneider, C. V., & Alqahtani, S. A. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.101359
Research progress of lysophosphatidylcholines in obesity-related metabolic diseases
Ye, H. O. N. G., Yan, N. I., & JunFen, F. U. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0084
Shao, C., Xu, L., Lei, P., Wang, W., Feng, S., Ye, J., & Zhong, B. (2023) · Figshare · doi:10.6084/m9.figshare.22603882
Liu, D., Guo, H., Yang, Y., He, X., & Zhao, X. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106548 · Cited by 3
Mason, E. J., Schraw, J. M., Woodhouse, J. P., Gramatges, M. M., Williams, K. J., Chen, B., Harrell, M. B., Taylor, O. A., Scheurer, M. E., Lupo, P. J., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10414-6 · Cited by 1
Reduction in Hepatic Phosphatidylcholine Biosynthesis Promotes MASH Through Copper DeficiencyPreprint
Welles, J. E., Garifallou, J. P., Gonzalez, M. V., Santoleri, D., Choudhury, F. K., DeNicola, G. M., Martin, R. W., Jiang, C., Kim, J., Li, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.13.723926
Xing, Y., Zheng, L., Xiao, Y., Ya, X., Xu, Q., Zeng, L., Hu, S., Ruan, D., & Wang, Z. (2026) · Molecules · doi:10.3390/molecules31122118
Misawa, K., Miura, K., Aizawa, K., Noguchi, E., Ueki, E., Watanabe, M., Osaka, H., & Yano, T. (2026) · Antioxidants · doi:10.3390/antiox15080950
Peschel, G., Weigand, K., Krautbauer, S., Höring, M., Liebisch, G., Müller, M., & Buechler, C. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2026.159773
Metadata
- Authors
- Tiwari-Heckler, S., Gan-Schreier, H., Stremmel, W., Chamulitrat, W., & Pathil, A.
- Affiliations
- Department of Internal Medicine IV, Gastroenterology and Hepatology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
- Heidelberg University (DE)
- Corresponding author
- Pathil, Anita
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-05-21
- Volume
- 10
- Issue
- 5
- Pages
- 649
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5986528
- OpenAlex
- W2803425795
- Cited by
- 96
- References
- 42
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 16 · 2023: 16 · 2022: 13 · 2021: 15 · 2020: 10 · 2019: 7
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- German Research Foundation (PA 2365/1-1)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, serum phospholipids, lipidomics, phosphatidylcholine, sphingomyelin, lysophosphatidylethanolamine, plasmalogens, linoleic acid, alpha-linolenic acid, hypertension, hyperglycemia, diabetes mellitus, liver fibrosis, metabolic risk factors
- MeSH terms
- Acyltransferases, Adult, Chromatography, High Pressure Liquid, Female, Germany, Humans, Lipase, Male, Membrane Proteins, Middle Aged, Phospholipids, Polymorphism, Genetic, Risk Factors, Biomarkers, Comorbidity, Case-Control Studies, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry, Elasticity Imaging Techniques, Phospholipases A2, Calcium-Independent, Metabolomics, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.